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Abstract
A20 negatively regulates multiple inflammatory signalling pathways. We here addressed
the role of A20 in club cells (also known as Clara cells) of the bronchial epithelium in their
response to influenza A virus infection. Club cells provide a niche for influenza virus replica-
tion, but little is known about the functions of these cells in antiviral immunity. Using airway
epithelial cell-specific A20 knockout (A20AEC-KO) mice, we show that A20 in club cells criti-
cally controls innate immune responses upon TNF or double stranded RNA stimulation.
Surprisingly, A20AEC-KO mice are better protected against influenza A virus challenge than
their wild type littermates. This phenotype is not due to decreased viral replication. Instead
host innate and adaptive immune responses and lung damage are reduced in A20AEC-KO
mice. These attenuated responses correlate with a dampened cytotoxic T cell (CTL)
response at later stages during infection, indicating that A20AEC-KO mice are better
equipped to tolerate Influenza A virus infection. Expression of the chemokine CCL2 (also
named MCP-1) is particularly suppressed in the lungs of A20AEC-KO mice during later stages
of infection. When A20AEC-KO mice were treated with recombinant CCL2 the protective
effect was abrogated demonstrating the crucial contribution of this chemokine to the protec-
tion of A20AEC-KO mice to Influenza A virus infection. Taken together, we propose a mecha-
nism of action by which A20 expression in club cells controls inflammation and antiviral CTL
responses in response to influenza virus infection.
Author Summary
Influenza viruses are a major public health threat. Each year, the typical seasonal flu epi-
demic affects millions of people with sometimes fatal outcomes, especially in high risk
groups such as young children and elderly. The sporadic pandemic outbreaks can have
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even more disastrous consequences. The protein A20 is an important negative regulator of
antiviral immune responses. We show that the specific deletion of A20 in bronchial epithe-
lial cells improves the protection against influenza virus infections. This increased protec-
tion correlates with a dampened pulmonary cytotoxic T cell response and a strongly
suppressed expression of the chemokine CCL2 during later stages of infection.
Introduction
Disease outcome upon exposure to a certain pathogen relies on the capacity of the host to resist
and tolerate the infection [1]. Resistance protects the host by suppressing pathogen replication
and promoting clearance of the pathogen, a process that is mostly mediated by the innate and
adaptive immune system. Tolerance refers to the ability to improve disease outcome without
affecting pathogen burden and by limiting tissue damage. An overactive immune response can
negatively impact on the disease by causing severe tissue damage [2]. Immunopathology is an
important contributor to death during exposure to highly virulent strains of influenza A such
as the 1918 H1N1 virus or highly pathogenic avian H5N1 and H7N1 viruses. The mechanisms
contributing to immune pathology during flu virus infection have been well documented, and
both innate and adaptive immunity seems to be involved [3–6]. However, the exact molecular
mechanisms regulating these processes are not well understood.
Detection of Influenza A by the innate immune system occurs by at least three different
mechanisms [7]. Firstly, the cytosolic receptor RIG-I detects 5’-triphosporylated influenza
virus genome segments [8,9]. In the absence of the viral non-structural protein 1 (NS1), RIG-I
induces a strong antiviral type-I interferon response [10]. Secondly, Toll-like receptors such as
TLR3 and TLR7 detect virus-associated RNA molecules. TLR7 is mainly employed by IFN pro-
ducing plasmacytoid dendritic cells, which produce large amounts of type-I IFN upon infection
with influenza virus [11,12]. TLR3, which recognizes double stranded RNA of yet undefined
origin, has been shown to influence disease outcome following influenza virus infection [13–
16]. Thirdly, the NOD-like receptor family member NLRP3 senses multiple influenza virus-
associated stimuli, including increased acidification of the cytoplasm mediated by the viroporin
M2, leading to the activation of caspase 1 and the release of the cytokines interleukin-1β (IL-
1β) and IL-18 [17–19].
A20 (TNF alpha-induced protein 3 or TNFAIP3) is a key player in the termination of
inflammation, and has been shown to regulate these innate signalling pathways [19–22]. We
previously showed that A20 in macrophages critically suppresses influenza virus-induced
innate immune responses and mice deficient in A20 in myeloid cells are protected against
influenza A virus infection. This protective effect is mediated by an enhanced innate immune
response and a better clearance of the virus [21].
Epithelial cells of the respiratory epithelium are the primary target cells of human influenza
viruses and main producers of infectious viral progeny [23]. Very little is known about the
physiological contribution of these cells to antiviral immunity. Epithelial cells have long been
considered as passive mediators in immunity, functioning primarily as physico-chemical barri-
ers preventing invading pathogens from entering the submucosal layers or the respiratory sys-
tem. It has become increasingly evident that epithelial cells also maintain important effector
functions directing both innate and adaptive immunity crucial for efficient antiviral responses
[24]. Respiratory epithelium actively contributes to pulmonary homeostasis [25], immunity
against viruses [26] and influenza induced immunopathology [27]. To study how A20 in epi-
thelial cells influences influenza A disease progression, we generated mice lacking A20
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specifically in bronchial epithelial cells (also known as club cells or Clara cells). We found that
these mice are protected against influenza A virus infection. This protection does not result
from an improved viral clearance or increased immune resistance to the virus, but correlates
with a dampened pulmonary CTL response and a strongly suppressed expression of the che-
mokine CCL2 during later stages of infection.
Results
A20 regulates inflammatory responses in club cells of the airway
epithelium
We studied the role of A20 in airway epithelial cells by crossing conditional A20 knockout
mice (A20FL/FL, S1A Fig) [28] with double transgenic animals carrying a reverse tetracycline
transactivator controlled by the rat CCSP promoter (CCSP-rTA) and a Cre recombinase under
control of the (TetO)7CMV operator [29,30]. This generated A20
FL/FL/CCSP-rTA/(tetO)7-Cre
triple transgenic offspring, hereafter referred to as A20AEC-KO mice. Treatment of these mice
with doxycycline enabled temporally controlled inactivation of the A20 gene specifically in
club cells (also known as Clara cells) [31], which constitute most of the epithelial cells found in
the proximal airways of the mouse respiratory tract [32]. To ensure deletion of A20 in club
cells at all times, breeding pairs and offspring were continuously maintained on a doxycycline
diet. A20AEC-KO mice were born at Mendelian ratios and displayed no developmental defects
or signs of spontaneous pulmonary inflammation.
Southern blot analysis on genomic DNA extracted from total lungs of A20AEC-KO mice and
control wild-type (A20WT) littermates showed Cre-mediated recombination of the A20FL/FL
allele only in lungs, but not in spleens, of A20AEC-KO mice (S1B Fig). Since club cells represent
a minor fraction of total lung tissue, only partial recombination was observed in total lung tis-
sue from A20AEC-KO mice. Semi-quantitative PCR analysis on genomic DNA isolated from var-
ious tissues of A20AEC-KO mice, confirmed the deletion of A20 specifically in lung tissue (S1C
Fig). As A20 is expressed at low levels in most cell types including airway epithelial cells, we
induced its expression by intratracheal instillation of LPS, a TLR4 agonist and known inducer
of A20 in lung epithelium [33]. Analysis of A20 expression of Club cells purified from the
lungs of A20AEC-KO mice by Western blot showed the absence of A20 at the protein level (S1D
Fig). Absence of A20 was finally confirmed by immunohistochemistry on lung tissue isolated
from A20AEC-KO mice (S1E Fig).
A20 is a negative regulator of multiple signalling pathways induced by inflammatory stimuli
including TNF and TLR ligands [34,35]. We tested if A20 also regulates these pathways in club
cells by intratracheal administration of TNF and poly(I:C), an agonist of the TLR3, RIG-I and
MDA5 signalling receptors [36,37]. We found increased numbers of neutrophils and mono-
cytes recruited into the bronchoalveolar space of A20AEC-KO mice compared to control litter-
mates upon engagement of these receptors (Fig 1A and 1C). Also significantly higher levels of
IL-6, CXCL1 (KC), CCL2 (MCP-1), but not TNF were detected in the bronchoalveolar lavage
(BAL) fluid of mice lacking A20 in club cells (Fig 1B and 1D). These results demonstrate that
A20 expression in club cells negatively controls inflammatory responses following exposure of
the airway to TNF and poly(I:C). These data are in accordance with previously published
results showing a similar regulatory role for A20 in various other cell types [34].
A20AEC-KO mice tolerate infections with influenza A virus
Since poly(I:C) is often used as a stimulus that mimics RNA virus infection, we next investi-
gated the in vivo role of A20 in club cells in a mouse model of influenza A virus (IAV)
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infection. We used the H3N2 mouse adapted influenza A strain X-47 in most of the experi-
ments [38]. Immunohistochemical staining of the club cell marker CCSP and the influenza A
ion channel protein M2, revealed that X-47 infected CCSP expressing club cells, along with
alveolar epithelial cells (S2A and S2B Fig). This allowed us to directly study the in vivo role of
A20 in the primary target cells of influenza A virus. A20AEC-KO had a clear survival advantage
compared to their control littermates following infection with a dose of X-47 virus that proved
lethal for most wild type mice (Fig 2A). Upon infection with a sublethal dose of X-47,
A20AEC-KO mice displayed less morbidity and weight loss at later stages (> 7 days) of infection
(Fig 2B). Challenge with A/Puerto Rico/8/34 (PR8, H1N1 subtype) influenza virus confirmed
the reduced susceptibility of A20AEC-KO mice to IAV infection (S3 Fig). This difference was
also evident by histological analysis of lung tissue from X-47-infected mice (Fig 2C and S4A
Fig) and by quantification of the total protein content in BAL fluid as a measure of lung dam-
age and vascular leakage (Fig 2D). We did not detect significant differences in viral titres in the
lungs of A20AEC-KO and A20WT mice at day 2 and day 5 post-infection (Fig 2E). These data
indicate that the disease protection in A20AEC-KO mice is likely not a consequence of an
enhanced intrinsic capacity of A20 deficient club cells to inhibit viral replication. The levels of
IFNα and IFNβ, cytokines with potent antiviral activity, and the IFN-inducible chemokine
CXCL10, were comparable in BAL fluid isolated from A20AEC-KO and A20WT animals at
Fig 1. A20 expression in club cells controls TNF and poly(I:C) induced inflammation. Intratracheal administration of 0.5μg TNF (A and B) or 50μg poly
(I:C) (C and D) to A20AEC-KO or wild type littermates (A20WT). Absolute numbers of neutrophils or monocytes in bronchoalveolar lavages (BAL) as determined
by flow cytometry at 6h and 24h post-treatment for TNF (A) or 24h post-treatment for poly(I:C) (C). IL-6, CXCL1 (KC), CCL2 (MCP-1) and TNF [only for poly(I:
C)] protein levels in BAL fluid detected by Multiplex immunoassay (B and D). Data represent mean ± SEM of at least 4 mice per group (*p < 0.05; Student’s t-
test).
doi:10.1371/journal.ppat.1005410.g001
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different time points post-infection, suggesting that the type-I IFN response is not differentially
regulated (S4B Fig). More importantly, we could not detect virus in the lungs of both
A20AEC-KO and A20WT mice at day 8 post infection (Fig 2E), which is the time during infection
where both groups of mice differ in morbidity. Finally, since A20 is known to confer protection
against cell death in multiple cell types (Catrysse et al., Trends Immunol., 2014), we assessed if
A20 deficiency in club cells could sensitize these cells to apoptosis after IAV infection. In none
of the assays performed, however, we could detect any significant difference in cell death
between A20AEC-KO lung samples and control samples (S5 Fig).
The absence of A20 in club cells thus significantly improves disease outcome upon influenza
A virus infection without altering viral clearance or type-I IFN responses. These data indicate
that A20AEC-KO mice are protected from influenza A virus infection by a mechanism that
involves increased tolerance, rather than increased antiviral resistance.
Fig 2. Deficiency of A20 in club cells protects against Influenza A infection. (A) Survival of A20AEC-KO (n = 30) or wild type littermates (A20WT, n = 28)
infected with a lethal dose of Influenza A X-47 (2 X LD50). (B) Weight loss of A20
AEC-KO (n = 6) or wild type littermates (A20WT, n = 8) monitored until 14 days
post infection (days p.i.) upon infection with a sublethal dose of X-47 (0.05 X LD50). (C) Representative pictures from hematoxylin and eosin stained lung
tissue sections from A20AEC-KO and control wild-type (WT) littermate mice at day 8 p.i. Detail, scale bar 100 μm (D) Total protein concentration using Bradford
assay in BAL fluid of A20AEC-KO and control A20AEC-WT littermates at different time points after sublethal IAV infection (n = between 3 and 11 for each time
point). *p < 0.05; ***p<0.001. (E) Pulmonary viral titers determined by TCID50 at 2, 5 and 8 days p.i. after infection with a sublethal dose (0.05 X LD50) of X-
47. Dashed line represents detection limit (ND = not detected). Data were pooled from 3 independent experiments and analyzed using Log-rank (A). Data are
representative of at least 2 independent experiments and were analysed using 2-way ANOVA (B, *p < 0.05) or Student’s t-test (C, ns = not significant) and
are shown as mean ± SEM.
doi:10.1371/journal.ppat.1005410.g002
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The pulmonary CTL response is dampened in A20AEC-KO mice
The late onset (> 7 days) of protection to influenza A of A20AEC-KO mice suggests that the
effect is driven by the adaptive immune system. Although viral clearance and host survival crit-
ically depend on the recruitment of virus-specific CD8+ cytotoxic T cells (CTL) to the lung,
influenza A-associated pulmonary immunopathology can be inflicted by an excessive antiviral
CTL response. CTLs are major producers of TNF during influenza A virus infection which is
known to contribute to immunopathology [5,39,40]. Analysis of CD8+ T cells by in vivo intra-
cellular cytokine staining showed that A20AEC-KO mice displayed reduced numbers of Gran-
zyme B, IFNγ and TNF expressing activated (CD62Llo) CD8+ T cells in the brochoalveolar
space and to a lesser extend in the lung tissue at day 8 post infection with X-47 virus (Fig 3A
and 3B). NP-pentamer staining of CD8+ T cells from the mediastinal lymph node, spleen and
BAL revealed that there was no significant difference between control and A20AEC-KO mice
(Fig 3C). This suggests that the extent of influenza antigen-specific CD8+ T cell priming is
comparable in the two mouse strains but that their activation in the lung compartment is dif-
ferent. A20AEC-KO mice also showed reduced levels of IFNγ and TNF protein levels in the BAL
Fig 3. The antiviral CTL response is attenuated in A20AEC-KO mice. (A and B) In vivo intracellular staining for Granzyme B (GrB), IFNγ, and TNF on
activated (CD62Llo) CD8+ T cells from BAL (A) and lungs (B) of A20AEC-KO or A20WT mice infected with 0.05 X LD50 X-47 at day 8 post infection. (C) NP-
specific pentamer staining of CD8+ T cells in BAL, spleens and mediastinal lymph nodes (MLN) of mice infected with 0.05 X LD50 X-47 measured at day 8 (D)
IFNγ, TNF and IL-10 protein levels measured by ELISA on BAL fluid collected from A20AEC-KO or A20WT mice infected with 0.05X LD50 X-47 at day 8 post
infection. Data are representative of 2 independent experiments and show as mean ± SEM of at least 6 mice per group (*p < 0.05; Student’s t-test).
doi:10.1371/journal.ppat.1005410.g003
A20 Controls Influenza Virus Infection
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fluid (Fig 3D). Upon entering the lung, effector CD8+ T cells are programmed to produce high
levels of the anti-inflammatory cytokine IL-10, which is an important mechanism to reduce
immunopathology [41]. Measurements of IL-10 in BAL fluid showed that also IL-10 levels are
lower in A20AEC-KO mice (Fig 3D). This indicates that the reduced CTL response in A20AEC-KO
mice is caused by a local signal from the pulmonary environment instead of a skewing of CD8+
T cells towards an anti-inflammatory phenotype.
A decreased CTL response can be the result of less effective priming of naïve T cells in the
lung draining lymph nodes. Activated antigen-loaded dendritic cells travelling from the lung to
the lung draining lymph nodes dictate the outcome of the CTL response [42]. However, we
found no significant differences in the accumulation of CD11b-, CD11b+ or inflammatory den-
dritic cells (iDC) in the lung draining mediastinal lymph nodes of A20AEC-KO mice compared
to control mice (S6A Fig). Furthermore, in vitro re-stimulation with NP peptide of single cell
suspensions prepared from spleens of A20WT and A20AEC-KO mice infected with X-47 showed
similar numbers of NP-specific CD8+ T cells as measured by IFNγ producing activated CD8+
T cells. In contrast, based on this restimulation assay, less NP-specific T cells responded to pep-
tide re-stimulation by inducing IFNγ expression in the lungs of A20AEC-KO mice (S6B Fig).
Loss of A20 in club cells did not affect antiviral humoral immunity as no significant differences
in the levels of X-47 neutralizing antibodies were observed in sera from challenged A20AEC-KO
mice compared to wild-type mice (S6C Fig).
Together, these data indicate that selective deletion of A20 in club cells suppresses the pul-
monary CTL response against influenza A virus leading to a decreased production of cytotoxic
CTL effector cytokines such as TNF.
CCL2 controls tolerance of A20AEC-KO mice to influenza A infection
We next addressed whether A20 deficiency in club cells and associated suppression of pulmo-
nary CTL responses affects the recruitment of innate immune cells to the lungs. The number of
recruited monocytes, neutrophils and macrophages in BAL was measured at different time
points after infection with X-47 virus. At late time points post-infection (> 5 days), the timing
at which A20AEC-KO mice show protection from influenza compared to control mice (Fig 2),
recruitment of monocytes and neutrophils was significantly lower in A20AEC-KO compared to
wild type mice (Fig 4A). CD11b- macrophages (“resident” macrophages) constituted the pre-
dominant macrophage population in the lung parenchyma of unchallenged mice and at early
time points post-infection, while the number of CD11b+ macrophages (“recruited” macro-
phages) increased, starting around day 5 and peaking around day 8 post-infection (Fig 4B).
The lungs of A20AEC-KO mice contained more CD11b- resident macrophages and alveolar mac-
rophages compared to control littermates at peak CTL response, 8 days post-infection, and this
difference sustained at later time points (Fig 4A and 4B).
Recruitment of macrophages to lungs is dependent on the chemokine CCL2 (MCP-1) [43–
45]. In agreement with the elevated levels of recruited monocytes and macrophages at day 8
post-infection in control A20WT mice, higher levels of CCL2 could be detected in BAL fluid
of these mice compared to A20AEC-KO littermates at this stage (Figs 4C and S7A). Other che-
mokines, such as KC (CXCL1) and Rantes (CCL5), were also differentially expressed in
A20AEC-KO and control A20WT mice at day 8 post-infection, although at lower levels (S7A Fig).
Immunohistochemical analysis of X-47-infected lung tissue confirmed enhanced CCL2 stain-
ing in CCSP+ lung epithelial cells from A20WT mice compared to A20AEC-KO mice (S7B Fig).
To assess the importance of reduced CCL2 levels in A20AEC-KO mice for their protective phe-
notype upon influenza virus infection, we administered recombinant mouse CCL2 (rCCL2) to
A20AEC-KO mice at day 6 post-infection. In contrast to control (PBS) treated A20AEC-KO mice,
A20 Controls Influenza Virus Infection
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Fig 4. Decreased CCL2 levels protect A20AEC-KO mice against influenza A infection (A) Absolute numbers of monocytes, neutrophils and alveolar
macrophages in bronchoalveolar lavages (BAL) of A20AEC-KO or A20WT mice at 2, 5, 8 and 12 days post-infection (days p.i.) with 0.05 X LD50 X-47. (B)
Absolute numbers of resident CD11b- or recruited CD11b+ macrophages in the lungs of A20WT and A20AEC-KO mice. (C) CCL2 (MCP-1) protein levels in BAL
fluid measured by Multiplex immunoassay at indicated time points post-infection. (D) Weight loss of A20AEC-KO and A20WT mice infected with 0.05 X LD50 X-
47. At day 6 p.i. (indicated by an arrow) mice received intranasal treatment with 50 μg/kg recombinant CCL2 (rCCL2) or PBS. Data were analysed using
Student’s t-test (A, B and C *p < 0.05) and 2-way ANOVA (D, *p < 0.05 for A20AEC-KO PBS vs. A20WT PBS and #p < 0.05 for A20AEC-KO PBS vs A20AEC-Cre
rCCL2). Data represent mean ± SEM of at least 3 mice per group. Data are representative of at least 2 independent experiments.
doi:10.1371/journal.ppat.1005410.g004
A20 Controls Influenza Virus Infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1005410 January 27, 2016 8 / 17
which again show protection from the virus challenge compared to wild-type littermates,
rCCL2 treated A20AEC-KO littermates mice are sensitized to infection and no longer show dif-
ferences compared to PBS or cCCL2 treated wild-type mice (Fig 4D). Together, these results
show that the protection of A20AEC-KO mice from infection results from a reduced CCL2-de-
pendent recruitment of innate immune cells to the lungs of infected mice.
Discussion
A20 is an essential negative regulator of NF-κB signaling, and A20 deficient mice die prema-
turely due to massive multi-organ inflammation triggered by infiltrating intestinal bacteria
[46,47]. We showed in this study that specific deletion of A20 in respiratory epithelial cells pro-
tects mice from Influenza A virus-induced morbidity and lethality. Viral clearance and the pro-
duction of the antiviral cytokines IFNα and IFNβ was similar in A20AEC-KO and wild-type
mice, in agreement with literature stating that epithelial cells are not the primary producers of
type-I IFNs upon respiratory virus infection [48]. Interestingly, although the initial recruitment
of innate cells and CTLs into the lungs of A20AEC-KO mice was sufficient to clear the virus by 8
days post infection, monocyte recruitment and the local CTL response in the lung were
markedly reduced during later stages of infection. This was rather surprising since A20 is char-
acterized as a negative regulator of the antiviral immune response [49]. Indeed we could con-
firm such a role for A20 in a surrogate viral infection model using intratracheal instillation of
the double stranded RNAmimic poly(I:C) showing hyperactive immune responses in AEC-
specific A20 knockout mice.
Protection of A20AEC-KO mice against influenza virus infection correlated with reduced
recruitment of monocytes and CD11b+ macrophages to the lungs. In line with this, the levels of
the monocyte-recruiting chemokine CCL2 were much lower in lungs of A20AEC-KO mice than
in wild type mice on days eight and twelve after infection. It has been reported that administra-
tion of an MCP-1/CCL2 blocking antibody can reduce mortality and morbidity following
influenza A virus infection [50]. Increased CCL2 levels have been reported in patients that had
been infected with H7N9 virus [51]. CCL2 contributes to tissue immunopathology following
influenza virus infection by its pro-inflammatory effects on macrophages and monocytes [52].
Recruitment of inflammatory macrophages in a manner dependent on the CCL2 receptor
CCR2 contributes substantially to lung damage [53]. In line with this, we found that intranasal
instillation of CCL2 in A20AEC-KO mice rendered these mice as susceptible to disease caused by
influenza A virus as wild type mice. In aggregate, the reduced levels of CCL2 in A20AEC-KO
mice could explain their increased tolerance to the infection. Yet after exposure of A20AEC-KO
mice to double stranded RNA, a surrogate viral PAMP, we observed increased levels of CCL2
compared to wild type controls. The latter observation is in line with the regulation of CCL2
expression by NF-κB [54]. So what caused the reduced levels of CCL2 in the A20AEC-KO mice
at later time points after influenza virus infection? It was remarkable that reduced disease,
lower CCL2 levels and decreased CD8+ T cell activation coincided. CCL2 expression can be
induced by IFNγ [55]. Therefore, the reduced numbers of IFNγ-producing CD8+ T cells could
explain the lower CCL2 levels and monocyte infiltration in the A20AEC-KO mice. Similarly
trans-presentation of TNF by influenza HA specific CD8+ T cells to lung epithelial cells has
been shown to induce strong expression of CCL2 leading to extensive lung injury due to infil-
trating monocytes. Increased CCL2 release by club cells might in addition recruit monocyte-
derived inflammatory dendritic cells into the lungs, which could sustain local CTL responses
and inflicting further damage to the lung [56,57]. Pro-inflammatory cytokine expression by
club cells contributes to immunopathology during later stages of influenza infection [27]. Our
study shows that expression of A20 in these cells might prevent lung damage by the host’s
A20 Controls Influenza Virus Infection
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immune system. The exact molecular mechanism of how the specific deletion of A20 in club
cells leads to increased tolerance to influenza infection is not understood at this moment and is
subject for future research.
In conclusion, these data show that loss of A20 in respiratory epithelium can protect mice
following Influenza A virus infection. In agreement with previous results, showing that deletion
of A20 in myeloid cells also protects from Influenza [21], these data suggest that inhibiting A20
expression, for example by local administration of interfering RNAs, might be promising as a
new therapeutic strategy to control disease caused by influenza A virus infection.
Materials and Methods
Ethics statement
All experiments on mice were conducted according to the national (Belgian Law 14/08/1986
and 22/12/2003, Belgian Royal Decree 06/04/2010) and European (EU Directives 2010/63/EU,
86/609/EEG) animal regulations. Animal protocols were approved by the Ethics Committee of
Ghent University (permit number LA1400091, approval ID 2010/001). All efforts were made
to reduce suffering of animals. Before procedures mice were anesthetised by intraperitoneal
(i.p.) injection of ketamine and xylazin.
Mice
Conditional A20 knockout mice harbouring two LoxP sequences flanking exon 4 and exon
5 (A20FL/FL) were generated as previously described [28] and were crossed with CCSP-rTA/
(tetO)7-Cre mice to specifically delete A20 in airway epithelial cells (AEC) (provided by Dr.
J. Whitsett, Cincinnati Children’s Hospital, USA) [29,58]. A20FL/FL/CCSP-rTA/(tetO)7-Cre tri-
ple transgenic offspring were fed doxycycline-containing food pellets to delete A20 expression
(625 mg/kg, Special Diet Services). All experiments were performed on age- and sex- matched
littermates. All mice used in this study carried the A20FL/FL and CCSP-rTA alleles. Those
expressing the (TetO)7 allele were termed A20
AEC-KO and those lacking this allele were consid-
ered as wild type controls (A20WT). Mice were housed in individually ventilated cages at the
VIB-UGent Inflammation Research Center (IRC) in a specific pathogen-free animal facility.
Poly (I:C) and TNF administration
After anesthetisation, mice received an intratracheal dose of 50 μg low molecular weight endo-
toxin-free poly(I:C) (Invivogen) or 0.5 μg recombinant mouse TNF (in house production) in
50 μl PBS. Six or 24 h after instillation mice were sacrificed and broncheoalveolar lavages
(BAL) were collected for flow cytometric analysis and cytokine / chemokine analysis.
Viruses
Mouse adapted influenza A X-47 (H3N2) and PR8 (H1N1) were propagated in MDCK
(Madin-Darby canine kidney, ATCC) cells. After anesthetisation, mice were infected intrana-
sally with X-47diluted in 50 μl PBS. For lethal and sublethal infections, mice received 2 X LD50
X-47 and 0.05 X LD50 X-47 or 0.17 X LD50 PR/8, respectively. Mice were euthanized when
weight loss exceeded 25% of the initial body weight. Recombinant mouse CCL2 (R&D Systems,
endotoxin levels<0.01 EU per μg of protein as measured by the LAL method) was adminis-
tered intranasally at a dose of 50 μg/kg at day 6 post infection. Pulmonary viral titres were
determined by median tissue culture infectious dose (TCID50) determination using MDCK
cells. Lungs were homogenized in PBS using a Polytron homogenizer (Kinematica) and ten-
fold serial dilutions of cleared lung homogenates were incubated on MDCK cells in DMEM
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supplemented with trypsin (1 μg/ml), 2 mM L-glutamine, 0.4 mM sodium pyruvate and antibi-
otics. After 5 days, 0.5% chicken red blood cells (RBC) were added to cell culture supernatant
and end-point dilution hemagglutination was monitored. TCID50 titres were calculated
according to the method of Reed and Muench [59]. HAI titres in serum of infected mice were
determined as follows: serum was treated for 18 h at 37°C with receptor-destroying enzyme
(RDE/Cholera filtrate, Sigma Aldrich) to remove sialic acids from serum proteins and prevent
nonspecific inhibition of agglutination. RDE was then inactivated by the addition of 0.75%
sodium citrate and heating at 56°C for 30 min. To remove sialic acid binding proteins, sera
were cleared with 1/10 volume 50% chicken RBC. Titration was done by incubating a two-fold
dilution series of sera with 4 HA units of X-47 for 1 h in 96-well U-bottom plate. An equal vol-
ume of 0.5% chicken RBC was then added and HAI titres were read after 30 min.
Club cell purification
The method for club cell isolation was adapted from [60]. Lungs were inflated with 0.25% tryp-
sin/HBSS and incubated in DMEM at 37°C for 20 min. After trypsin neutralisation with FCS,
lungs were cut into small 1 mm3 sections and sequentially filtered without homogenisation
through a 40 μm cell strainer. The cells were then placed into a humidified incubator at 37°C
for 2 h to remove adherent cell populations (macrophages and fibroblasts). Club cells were spe-
cifically pelleted by centrifugation at 30 g for 8 min.
Flow cytometry
Lungs and mediastinal lymph nodes (MLN) were dissected into small 1 mm3 sections and
incubated with collagenase type IV (1 mg/ml, Worthington) and DNase I (100 U/ml, Roche) at
37°C for 30 min. Subsequently, samples were filtered and homogenised through a 40 μm cell
strainer. For BAL, tracheas were cannulated and lungs were flushed 4 times with HBSS with 1
mM EDTA. The first ml was treated with EDTA-free protease inhibitor tablets (Roche) and
frozen separately for cytokine/chemokine analysis. After treatment with red blood cell lysis
buffer (Sigma Aldrich), cells were stained with monoclonal antibodies directed against MHC-II
(I-A/I-E) (M5/114.15.2), CD11c (N418) CD8α (53–6.7), F4/80 (BM8), CD62L (MEL-14),
Granzyme B (NGZB) B220 (RA3-6B2) from eBiosciences and CD45 (30-F11), CD3ε (500A2),
Gr1 (RB6-8C5), Ly6G (1A8), Ly6C (AL-21) CD11c (HL3), CD11b (M1/70), CD4 (GK1.5),
CD8α (53–6.7), IFNγ (XMG1.2), TNF (MP6-XT22) and CD16/32 (2.4G2) from BD Pharmin-
gen. Samples were acquired on a LSRII Cytometer (BD Biosciences) and analysis was per-
formed using FACSDiva software (BD Biosciences).
Immunohistochemistry
Lungs were inflated with 4% paraformaldehyde. After 1 hour lungs were washed in PBS and
embedded in paraffin. 5 μm thick tissue sections were cut from paraffin blocks. For immuno-
histochemistry, sections were dewaxed, dehydrated and incubated in Dako antigen retrieval
solution, brought to boiling temperature and allowed to cool down for 2 hours. Endogenous
peroxidase activity was blocked by immersing slides in 3% H2O2 for 5 min. Sections were
blocked and permeabilized in 10% goat serum and 1% Triton X-100. Sections were incubated
overnight at 4°C in blocking buffer with anti-M2 (in house preparation) and anti-CCSP
(Abcam) antibody. Subsequently, slides were incubated with secondary antibody for 1 h (poly-
mer HRP-labelled anti-mouse/rabbit/rat; Vector Laboratories) and peroxidase was detected by
diaminobuteric acid (DAB) substrate (Sigma Aldrich). Tissue sections were counterstained
with Mayer’s haematoxylin, rehydrated and mounted in Pertex mounting medium (Histolab).
For A20 staining, sections were incubated for 60 min at 4°C in blocking buffer with anti-A20
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(ProSci) antibody, and subsequently with HRP-labeled anti-rabbit IgG and FITC-labeled anti-
HRP. For CCL2/MCP1 staining, sections were incubated for 30 min with anti-CCL2 (Abcam,
clone ECE.2) antibody, followed by Cy3-labeled anti-rat antibody.
In vitro and in vivo intracellular staining of activated T cells
For in vitro peptide stimulation, 5 x 106 cells isolated from spleen or lungs of animals infected
with X-47 were stimulated with different concentrations of NP-peptide (ASNENMETM, JPT
peptide solutions). After 18h, brefeldin A was added to the cell culture and after 6 h cells were
collected and stained for cell surface markers and IFNγ. In vivo intracellular staining for GrB,
IFNγ and TNF from freshly isolated BAL and lungs was performed as described previously
[61]. Mice were treated intranasally with 50 μg brefeldin A (Sigma Aldrich) 6 h before tissue
collection and single cell suspensions from BAL and lungs were prepared in the presence of
3 μg/ml brefeldin A. Cells were stained for cell surface markers and intracellular molecules and
fixed and permeabilized in Cytofix / Cytoperm (BD biosciences) according to manufacturer’s
instructions. Activated CD8+ T cells were identified as CD3ε+, CD8α+ and CD62Llo. Live/
Dead fixable aqua dead cell stain (Molecular Probes) was used to discriminate live from dead
cells.
Pentamer staining
Spleens, mediastinal lymph nodes and bronchoalveolar lavage (BAL) fluid were isolated from
infected and non-infected mice. Single cell suspensions were prepared in PBS containing 0.5%
BSA. After removal of red blood cells by osmotic lysis, cells were stained with Aqua Live/Dead
(Life Technologies), anti-CD16/CD32 (clone 2.4G2; Fc Block; Becton Dickinson Biosciences),
anti-CD19 (clone 1D3; Becton Dickinson Biosciences), anti-CD3ε (clone 17A2; Becton Dickin-
son Biosciences), anti-CD8α (clone 53–6,7; Becton Dickinson Biosciences) and H-2Db
ASNENMETM pentamer (ProImmune) for 25 minutes at 4°C. Prior to measurements,
CountBright Absolute Counting Beads were added to each sample. Cells were measured on a
BD LSR II cytometer (BD Biosciences) and analysed using FlowJo software (Tree Star).
Cytokine quantification
Detection of CCL2 (MCP-1), CCL5 (Rantes), CXCL1 (KC), IL-6 and TNF in BAL fluid was
performed using Multiplex immunoassay technology (BioRad). IFNγ, IL-10 (eBioscience)
IFNβ and IFNα (R&D Systems and Invivogen) protein levels were determined by ELISA.
Western, Southern blotting and genomic PCR
For Western blotting, cells were lysed at 4°C for 15 min in lysis buffer (200 mMNaCl, 1% NP-
40, 10 mM Tris-HCl pH 7.5, 5 mM EDTA and 2 mMDTT) supplemented with protease and
phosphatase inhibitors. Cell lysates were subsequently separated by SDS-PAGE and analyzed
by western blotting and ECL detection (Perkin Elmer Life Sciences). Immunoblots were
revealed with anti-A20 (Santa Cruz), anti-actin (MP Biomedicals) and HRP-linked anti-mouse
(GE Healthcare) antibodies. For Southern blotting, genomic DNA was digested with BamHI
yielding 6.5- and 13.5-kb fragments for A20 floxed and deleted alleles, respectively. DNA was
separated on an agarose gel and transferred to a nitrocellulose membrane. Hybridization was
performed with a 32P-labeled probe. A20 specific genomic PCR was performed using the fol-
lowing primers: 5’-CAC AGA GCC TCA GTA TCA TGT-3’, 5’-CCT GTC AAC ATC TCA
GAA GG-3’ and 5’ GCA GCT GGA ATC TCT GAA ATC 3’.
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Cell death measurement
Apoptosis was analysed by fluorescence microscopy using an in situ cell death detection kit
(Roche). Caspase activity was measured by incubation of 25 μg tissue homogenate with 50 μM
acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-amc) (Peptide Institute, Osaka,
Japan) in 150 μl cell-free system buffer (10 mMHEPES–NaOH pH 7.4, 220 mMmannitol,
68 mM sucrose, 2 mMNaCl, 2.5 mM KH2PO4, 0.5 mM EGTA, 2 mMMgCl2, 5 mM pyruvate,
0.1 mM PMSF, 1 mM dithiothreitol). The release of fluorescent 7-amino-4-methylcoumarin
was measured for 50 min at 2-min intervals by fluorospectrometry at 360 nm excitation and
480 nm emission wavelength, using a Cytofluor device (PerSeptive Biosystems, Cambridge,
MA). The maximal rate of increase in fluorescence was calculated (Δfluorescence/min). Lungs
were prepared as described for flow cytometric analysis and cells were stained with antibodies
directed against CD326 (EpCAM, eBioscience clone G8.8), CD45 and CD31 (eBioscience,
clone 390). Prior to flow cytometric analysis cells were washed and incubated with Annexin V
and propidium iodide in Annexin V binding buffer according to manufacturer’s instructions
(BD Biosciences).
Statistics
Data were analysed using GraphPad Prism Software. Results are expressed as the mean ± SEM.
Statistical significance between experimental groups was assessed using an unpaired two-sam-
ple Student’s t test. Statistical significance of differences between survival rates was analysed by
comparing Kaplan-Meier curves using the log-rank test.
Supporting Information
S1 Fig. Analysis of A20 (Tnfaip3) deletion in club cells of A20AEC-KO mice. (A) Scheme of
conditional A20 gene targeting. Boxes indicate exons 1–9 (E1-E9; black boxes depict coding
sequence). E4 and E5 are flanked by 2 LoxP sites (arrowhead). Restriction enzymes (B, BamHI
and V, EcoRV) and the location of the probe for Southern Blot analysis are also annotated. (B)
Southern blot on genomic DNA isolated from spleens and lungs of A20AEC-KO or A20WT mice.
DNA from heterozygous (A20+/-) MEFs was used as a control. (C) A20 specific PCR using
primers that discriminate between floxed and deleted A20 alleles on genomic DNA isolated
from lungs of A20WT or A20AEC-KO mice or DNA from different organs of A20AEC-KO mice.
(D) Western blot for A20 and actin on club cells purified from lungs of A20WT or A20AEC-KO
mice after intratracheal instillation of 1 μg LPS for 24 hours. (E) Immunohistological section of
A20WT and A20AEC-KO lung tissue stained with anti-A20 antibody (green). Cell nuclei are
staining with DAPI. Scale bar 20μm.
(TIF)
S2 Fig. Influenza A X-47 infects CCSP expressing club cells and IFNα expression after X-
47 challenge. (A) Immunohistochemical stain for CCSP on lung sections of wild type mice
(upper scale bar 50μm, lower scale bar 20μm). (B) Immunohistochemical stain for influenza A
M2 protein on wild type mice mock (left) or X-47 virus infected (right) analyzed 4 days (4d)
after infection (upper scale bar 50μm, lower scale bar 20μm). Lower panels represent magnifi-
cations of boxed sections of upper panels. Arrows indicate M2-positive alveolar epithelial cells.
(TIF)
S3 Fig. Deficiency of A20 in club cells protects against PR8 IAV infection.Weight loss of
A20AEC-KO (n = 6) or wild type littermates (A20WT, n = 9) monitored until 14 days post infec-
tion (days p.i.) with a sublethal dose of the A/Puerto Rico/8/34 (PR8) strain (0.17 X LD50).
A20 Controls Influenza Virus Infection
PLOS Pathogens | DOI:10.1371/journal.ppat.1005410 January 27, 2016 13 / 17
Data were analysed using 2-way ANOVA (p< 0.05) and are shown as mean ± SEM.
(TIF)
S4 Fig. Lung histology and IFNα expression after X-47 challenge. (A) Representative pictures
from hematoxylin and eosin stained lung tissue sections from A20AEC-KO and control wild-type
(WT) littermate mice at different times p.i. Scale bar, 100 μm. (B) IFNα, IFNβ, and CXCL10 pro-
tein levels in BAL fluid of A20AEC-KO mice and control littermates as determined by ELISA on
different time points after sublethal challenge with X-47. Data represent mean ± SEM of at least 4
mice per group. Data are representative of 2 independent experiments.
(TIF)
S5 Fig. Influenza A X-47 infection does not significantly increase club cell apoptosis in
A20AEC-KO mice. (A) DEVDase assay to quantify caspase-3 activity in tissue homogenates of
lungs of A20AEC-KO and control littermates (A20WT) at different days post infection (days p.i.)
with 0.05 X LD50 of X47 virus. Data are shown as mean ± SEM of at least 4 mice per group
(p< 0.05; 2-way ANOVA). (B) Flow cytometric Annexin V staining of EpCAM+ lung epithe-
lial cells on collagenase type IV and DNase I digested lung tissue of A20AEC-KO or A20WT mice
infected with 0.05 X LD50 X-47 at day 8 post infection. (C) Representative pictures from
TUNEL stained lung tissue sections from A20AEC-KO and control wild-type (WT) littermate
mice at different times p.i. Scale bar, 100 μm.
(TIF)
S6 Fig. DC kinetics in MLN and peripheral adaptive immune responses are not altered in
A20AEC-KO mice. (A) Absolute numbers of CD11b-, CD11b+ and inflammatory DCs (iDC) in
mediastinal lymph nodes (MLN) measured by flow cytometry at 2, 5, 8 and 12 days post-infec-
tion (days p.i.) after challenge with 0.05 X LD50 X-47. (B) Cells isolated from lungs or spleens
at day 8 p.i. were stimulated with indicated amounts of NP peptide (ASNENMETM). After
18h, brefeldin A was added for 6h and IFNγ expressing (IFNγ+) activated (CD62Llo) CD8+ T
cells were analyzed using flow cytometry. (C) Virus specific antibody titers in serum at 12 and
20 days p.i. as determined by hemagglutination inhibition (HAI) assay (ND = not detected).
Data show the results of 1 (A and B) or 2 (C) independent experiments and were analyzed
using Student’s t-test (p< 0.05) and are represented as mean ± SEM.
(TIF)
S7 Fig. Reduced CCL2 expression in CCSP expressing club cells from A20AEC-KO mice after
influenza A virus infection. (A) CCL2 (MCP-1), KC (CXCL1) and Rantes (CCL5) protein lev-
els in BAL fluid measured by Multiplex immunoassay at indicated time points post-infection.
(B) Immunohistological section of inflamed A20WT and A20AEC-KO lung issue stained with
anti-CCL2 (white) and anti-CCSP (red) at day 7 post-infection. Cell nuclei are staining with
DAPI. Scale bar upper panels 50 μm, lower panels 10 μm.
(TIF)
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